Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CNS Metabolic Disorders”

4,028 trials

Showing 20 of 4,028 results

Large-scale testing (Phase 3)Study completedNCT00478647
What this trial is testing

Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase

Who this might be right for
Gaucher Disease
Shire 40
Testing effectiveness (Phase 2)Study completedNCT00036413
What this trial is testing

A 12-week, Multicenter, Safety and Dose-ranging Study of 3 Oral Doses of TCH346 in Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Novartis Pharmaceuticals 44
Not applicableLooking for participantsNCT03564561
What this trial is testing

Natural History of Pompe Disease

Who this might be right for
Glycogen Storage Disease Type II, Adult
Assistance Publique - Hôpitaux de Paris 20
Not applicableStudy completedNCT05334342
What this trial is testing

Low-GI Diet Vs High-GI Diet in Individuals with SCI

Who this might be right for
Spinal Cord InjuriesPostprandial HypotensionGlucose Metabolism Disorders
Ohio State University 11
Not applicableWithdrawnNCT05497817
What this trial is testing

Evaluate Caregiver Connections Via Technology for Patients With Alzheimer's and Other Types of Dementia

Who this might be right for
Caregiver StressDementiaAlzheimer Dementia+3 more
Mayo Clinic
Not applicableUnknownNCT02000310
What this trial is testing

Molecular and Cellular Mechanisms of Lysosomal Storage Diseases

Who this might be right for
Lysosomal Storage Disorders
O & O Alpan LLC 80
Testing effectiveness (Phase 2)Study completedNCT00814346
What this trial is testing

Effect of EGb761® on Brain Glucose Metabolism in Three Groups of Elderly Defined by Cognitive Functions

Who this might be right for
Alzheimer's DiseaseCognitive Impairment
Ipsen 49
Not applicableStudy completedNCT04058327
What this trial is testing

MHE in Patients With Liver Diseases

Who this might be right for
Hepatic EncephalopathyMinimal Hepatic EncephalopathyOvert Hepatic Encephalopathy
Qin Ning 252
Not applicableEnded earlyNCT04008849
What this trial is testing

A Follow-up Study in Patients With Inherited Metabolic Disorders (IMD) Who Underwent Hematopoietic Stem Cell Transplantation (HSCT) With MGTA-456

Who this might be right for
Inherited Metabolic Disorders (IMD)
Magenta Therapeutics, Inc. 3
Not applicableStudy completedNCT03613038
What this trial is testing

A Systematic Investigation of Phonetic Complexity Effects on Articulatory Motor Performance in Progressive Dysarthria

Who this might be right for
Amyotrophic Lateral SclerosisParkinson Disease
University of Missouri-Columbia 100
Not applicableEnrolling By InvitationNCT05433948
What this trial is testing

Diagnosing Minimal Hepatic Encephalopathy

Who this might be right for
Hepatic EncephalopathyLiver Cirrhosis
Esbjerg Hospital - University Hospital of Southern Denmark 550
Testing effectiveness (Phase 2)UnknownNCT04318626
What this trial is testing

The Influence of [18F]PMPBB3 and [18F]THK5351 PET Distribution Patterns on Post-stroke Cognitive Impairment

Who this might be right for
Post-stroke Cognitive ImpairmentNeuroinflammation
Chang Gung Memorial Hospital 80
Testing effectiveness (Phase 2)Study completedNCT04251585
What this trial is testing

Intranasal Insulin in Parkinson's Disease

Who this might be right for
Parkinson Disease
HealthPartners Institute 31
Testing effectiveness (Phase 2)Study completedNCT00005674
What this trial is testing

Clinical Trial of Creatine in Amyotrophic Lateral Sclerosis [ALS]

Who this might be right for
Amyotrophic Lateral Sclerosis
National Center for Research Resources (NCRR)
Testing effectiveness (Phase 2)Study completedNCT02676843
What this trial is testing

Tau PET Imaging With 18F-AV-1451 in Subjects With MAPT Mutations

Who this might be right for
Frontotemporal Lobar Degeneration (FTLD)Frontotemporal Dementia (FTD)Tauopathies
Columbia University 7
Testing effectiveness (Phase 2)Ended earlyNCT05053035
What this trial is testing

Evaluate AL001 in C9orf72-Associated ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Alector Inc. 5
Not applicableStudy completedNCT00024908
What this trial is testing

Test of A Model of Representational Knowledge Stored in the Human Prefrontal Cortex

Who this might be right for
Intracranial Central Nervous System DisorderMental DisorderHealthy
National Institute of Neurological Disorders and Stroke (NINDS) 949
Not applicableActive Not RecruitingNCT04848779
What this trial is testing

A Prospective Study to Observe & Describe Clinical Outcomes of Alglucosidase Alfa Treatment in Patients ≤6 Months of Age With Infantile-onset Pompe Disease (IOPD)

Who this might be right for
Glycogen Storage Disease Type II
Sanofi 16
Testing effectiveness (Phase 2)WithdrawnNCT02715505
What this trial is testing

Safety and Exploratory Efficacy of HSC835 in Patients With Inherited Metabolic Disorders (IMD)

Who this might be right for
Inherited Metabolic Disorders IMD
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Active Not RecruitingNCT04584983
What this trial is testing

Bilirubin Neurotoxicity (BN) and Neurodevelopmental Impairment (NDI) in Extremely Preterm (EP) Infants: Avoidable by Reducing the Usual Intravenous Lipid (UL) Administration

Who this might be right for
Bilirubin Encephalopathy
The University of Texas Health Science Center, Houston 134
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation